Cyclohexyl prostaglandin analogs as EP 4 -receptor agonists

Details Cyclohexyl prostaglandin analogs as EP 4 -receptor agonists Cyclohexyl prostaglandin analogs as EP 4 -receptor agonists

2006-03-21

2006-03-21

Solola, Taofiq (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S529000, C549S032000, C560S008000, C560S129000

Reexamination Certificate

active

07015243

ABSTRACT:
The invention relates to the use of novel cyclohexyl analogues of E-type prostaglandins as EP4agonists, in general, and, in particular as ocular hypotensives. The cyclohexyl analogues used in accordance with the invention are represented by the following formula I:wherein the wavy segments represent α or β bond, dashed line represents the presence or absence of a bond W, Y, Z, R, R1, R2and R3are as defined in the specification.

REFERENCES:
patent: 3985798 (1976-10-01), Floyd, Jr. et al.
patent: 4060540 (1977-11-01), Bernady et al.
patent: 4994274 (1991-02-01), Chan et al.
patent: 5028624 (1991-07-01), Chan et al.
patent: 5034413 (1991-07-01), Chan et al.
patent: 5446041 (1995-08-01), Chan et al.
patent: 6531614 (2003-03-01), Conrow
Brawner et al, “Prostaglandins and congeners. 21. Synthesis of some cyclohexyl analogs”, XP002310257, Journal of Organic Chemistry, 44(1), 71-5, 1979.
Lopez-Pelegrin et al, “Solution-and soluble-polymer supported asymmetric synthesis of six-membered ring prostanoids”, SP002310258, Chemistry-A European Journal, 6(11) 1917-1922, 2000.
Ohuchida et al, “Synthesis of thromboxane A2 analogs-3. (+)-Thiathromboxane A2”, XP002310259, Tetrahedron, 39(24), 4269-72, 1983.
Crossley et al, “Cyclohexane analogs of the prostaglandins”, XP002310260, Tetrahedron Letters, (36), 3327-30, 1971.
Bito, L.Z.,Biological Protection with Prostaglandins, “Prostaglandins and Related Compounds as Potential Ocular Therapeutic Agents”, vol. 1, Chapter 18, 1985, pp. 231-252.
Bito, L.Z.,Glaucoma, Applied Pharmacology in the Medical Treatment, “Prostaglandins, Other Eicosanoids, and Their Derivatives as Potential Antiglaucoma Agents”,1984, Chapter 20, pp. 477-505.
Nilsson et al, Invest. Ophthalmol. Vis. Sci. (suppl), 284 (1987), Arvo Abstracts 9-6:00.
Bito, L.Z., Arch. Ophthalmol. “Prostaglandins” “Old Concepts and New Perspectives”, vol. 105, pp. 1036-1039 (1987).
Siebold et al, Prodrug 5 3, “Esterified protaglandin shows ‘potent’ promise”,1989.
Lopez-Pelegrin et al, “Solution- and Soluble-Polymer Supported Asymmetric Synthesis of Six-Membered Ring Prostanoids”, Chem. Eur. J. 2000, 6, 1917-1922.
Hareau et al, “Synthesis of Optically Active 5-(tert-Butyldimethylsiloxy)-2-cyclohexenone and Its 6-Substituted Derivatives as Useful Chiral Building Blocks for the Synthesis of Cyclohexane Rings. Syntheses of Carvone, Penienone, and Penihydrone”, J. Am. Chem. Soc. 1999, 121, 3640-3650.

Affiliated with

Also associated with

Rating

Cyclohexyl prostaglandin analogs as EP 4 -receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclohexyl prostaglandin analogs as EP 4 -receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclohexyl prostaglandin analogs as EP 4 -receptor agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3569113